George Kemble

CIK: 0001858176

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)4 (40.0%)

Position reduction

Option Exercises (M)4 (40.0%)

Derivative conversions

Awards (A)2 (20.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

SGMT

Sagimet Biosciences Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (10 total)

SGMT
Sagimet Biosciences Inc.
Aug 14, 2026
Sale(S)
Direct
351K shares at avg. $10.23$3.6M
SGMT
Sagimet Biosciences Inc.
Aug 14, 2026
Exercise(M)
Direct
24.4K shares at avg. $6.36$155K
SGMT
Sagimet Biosciences Inc.
Aug 14, 2026
Exercise(M)
Direct
326.6K shares at avg. $6.36$2.1M
SGMT
Sagimet Biosciences Inc.
Aug 11, 2026
Exercise(M)
Direct
10.5K shares at avg. $6.36$66K
SGMT
Sagimet Biosciences Inc.
Aug 11, 2026
Exercise(M)
Direct
9.8K shares at avg. $6.36$62K
SGMT
Sagimet Biosciences Inc.
Aug 11, 2026
Sale(S)
Direct
20.2K shares at avg. $9.95$201K
SGMT
Sagimet Biosciences Inc.
Jul 20, 2026
Sale(S)
Direct
18.8K shares at avg. $7.46$141K
SGMT
Sagimet Biosciences Inc.
Jun 12, 2026
Award(A)
Stock Option (Right to Buy)
Direct
39.6K shares-
SGMT
Sagimet Biosciences Inc.
Nov 20, 2025
Sale(S)
Direct
37.7K shares at avg. $7.69$290K
SGMT
Sagimet Biosciences Inc.
Jun 9, 2025
Award(A)
Stock Option (Right to Buy)
Direct
32.3K shares-

		Type	Shares	Price		Ownership
Aug 14, 2026	SGMT Sagimet Biosciences Inc.	Sale(S)	350,987	$10.23	$3,591,580	Direct
Aug 14, 2026	SGMT Sagimet Biosciences Inc.	Exercise(M)	24,369	$6.36	$154,987	Direct
Aug 14, 2026	SGMT Sagimet Biosciences Inc.	Exercise(M)	326,618	$6.36	$2,077,290	Direct
Aug 11, 2026	SGMT Sagimet Biosciences Inc.	Exercise(M)	10,455	$6.36	$66,494	Direct
Aug 11, 2026	SGMT Sagimet Biosciences Inc.	Exercise(M)	9,751	$6.36	$62,016	Direct
Aug 11, 2026	SGMT Sagimet Biosciences Inc.	Sale(S)	20,206	$9.95	$201,147	Direct
Jul 20, 2026	SGMT Sagimet Biosciences Inc.	Sale(S)	18,844	$7.46	$140,529	Direct
Jun 12, 2026	SGMT Sagimet Biosciences Inc.	Award(A) Stock Option (Right to Buy)	39,567	-	-	Direct
Nov 20, 2025	SGMT Sagimet Biosciences Inc.	Sale(S)	37,688	$7.69	$289,979	Direct
Jun 9, 2025	SGMT Sagimet Biosciences Inc.	Award(A) Stock Option (Right to Buy)	32,250	-	-	Direct

1-10 of 10 transactions

About Kemble George

Kemble George (SEC CIK 0001858176) files insider reports with the SEC as Director of Sagimet Biosciences Inc. (SGMT).

Signal8 holds 6 ownership filings by Kemble George, all Form 4s, filed between Jun 10, 2025 and Aug 17, 2026. Those filings report 10 transactions, from Jun 9, 2025 to Aug 14, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Kemble George's filings is in FOSTER CITY, CA.

Recent filings by Kemble George

Aug 14, 2026: Open-market sale of SGMT shares (Form 4, code S).
Aug 14, 2026: Option exercises of SGMT shares (2 lines, Form 4, code M).
Aug 11, 2026: Option exercises of SGMT shares (2 lines, Form 4, code M).
Aug 11, 2026: Open-market sale of SGMT shares (Form 4, code S).
Jul 20, 2026: Open-market sale of SGMT shares (Form 4, code S).

Other insiders filing for Sagimet Biosciences Inc. (SGMT)

Happel David, President & CEO
Rozek Elizabeth, Chief Legal & Admin. Officer
SEIDENBERG BETH C, Director
Hoelscher Paul W., Director
Jarrett Jennifer, Director
GRAMMER ELIZABETH A, Director

How to read Form 4 transaction codes